Can fortwin and phergan given to patient post delivery
Fortwin pentazocine Phenergan promethazine post delivery postpartum use safety
pentazocine promethazine post delivery postpartum breastfeeding safety
| Drug | Generic Name | Class |
|---|---|---|
| Fortwin | Pentazocine | Opioid agonist-antagonist analgesic |
| Phenergan | Promethazine | Phenothiazine antihistamine / antiemetic / sedative |
| Situation | Recommendation |
|---|---|
| Post-normal delivery (vaginal), breastfeeding planned | Use cautiously; prefer NSAIDs/paracetamol as first-line; if opioid needed, use lowest effective dose; monitor for lactation delay |
| Post-cesarean, moderate-severe pain | Can be used short-term; reduce doses; monitor neonate for sedation if breastfeeding |
| Mother not breastfeeding | Can be used more freely for acute pain; monitor maternal sedation and respiratory status |
| Early postpartum (first 24-48 hours) | Avoid if possible - highest risk period for interfering with lactation establishment |
| Dysphoria/psychotomimetic effects | Pentazocine notably causes dysphoria, hallucinations, and psychotomimetic effects - watch for this in the postpartum period |
Dose of fortwin and phenarga and which route to be given to patient immediate postpartum
pentazocine promethazine dose route IM IV immediate postpartum obstetrics India
fortwin 30mg phenergan 25mg IM postpartum dose obstetrics textbook
pentazocine 30mg IM subcutaneous dose frequency analgesia obstetrics postpartum pain
| Drug | Dose | Route | Frequency | Max per 24 hrs |
|---|---|---|---|---|
| Fortwin (Pentazocine) | 30 mg | IM (preferred) / SC / IV | Every 3-4 hours as needed | 360 mg/day |
| Phenergan (Promethazine) | 25 mg | IM (preferred) / slow IV | Every 4-6 hours as needed | 100 mg/day |
IV route - if used, give 20 mg slowly; rapid IV can cause severe hypotension and respiratory depression
| Concern | Action |
|---|---|
| Breastfeeding mother | Use lowest dose for shortest time; observe neonate for sedation and poor feeding |
| Promethazine may delay lactation onset | Avoid in first 24-48 hrs if possible; if needed, encourage frequent feeding attempts |
| Respiratory monitoring | Monitor mother's SpO2 and RR for at least 1 hour after injection |
| Avoid in newborn/neonate directly | Never give Phenergan to a neonate (fatal respiratory depression risk under 2 years) |
| Dysphoria/hallucinations | Pentazocine's kappa-opioid effect can cause these - warn patient; reassure if they occur |